|
|
Blood, 15 October 2006, Vol. 108, No. 8, pp. 2789-2795.
Prepublished online as a Blood First Edition Paper on June 20, 2006; DOI 10.1182/blood-2006-05-025676.
Previous Article | Table of Contents | Next Article 
NEOPLASIA
Dysregulation of IL-15-mediated T-cell homeostasis in TGF- dominant-negative receptor transgenic mice
Philip J. Lucas,
Seong-Jin Kim,
Crystal L. Mackall,
William G. Telford,
Yu-Waye Chu,
Frances T. Hakim, and
Ronald E. Gress
From the Experimental Transplantation and Immunology Branch, the Laboratory of Cell Regulation and Carcinogenesis, and the Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
T-cell subpopulations, defined by their expression of CD4, CD8, naive, and memory cell-surface markers, occupy distinct homeostatic compartments that are regulated primarily by cytokines. CD8+ memory T cells, as defined by CD44hi surface expression, are dependent on IL-15 as a positive regulator of their homeostatic maintenance. Manipulation of IL-15 signaling through gene aberration, overexpression, or receptor alterations has been shown to dramatically affect T-cell homeostasis, with overexpression leading to fatal leukemia. Here we show that TGF- is the critical negative regulator of murine CD8+ memory T-cell homeostasis with direct opposition to the positive effects of IL-15. This negative regulation is mediated, at least in part, by the ability of TGF- to modulate expression of the -chain of the IL-15 receptor, thus establishing a central axis between these 2 cytokines for homeostatic control of CD8+ memory T-cell populations. These data establish TGF- as a critical and dominant tumor-suppressor pathway opposing IL-15-mediated CD8+ T-cell expansion and potential malignant transformation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-s. Wang, G.-q. Wang, Y.-j. Wen, L. Wang, X.-c. Chen, P. Chen, B. Kan, J. Li, C. Huang, Y. Lu, et al.
Immunity against Tumor Angiogenesis Induced by a Fusion Vaccine with Murine {beta}-Defensin 2 and mFlk-1
Clin. Cancer Res.,
November 15, 2007;
13(22):
6779 - 6787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Miller, D. J. Weisdorf, L. J. Burns, A. Slungaard, J. E. Wagner, M. R. Verneris, S. Cooley, R. Wangen, S. K. Fautsch, R. Nicklow, et al.
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone
Blood,
October 1, 2007;
110(7):
2761 - 2763.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |